lactic acid has been researched along with Hemophilia B in 2 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Hemophilia B: A deficiency of blood coagulation factor IX inherited as an X-linked disorder. (Also known as Christmas Disease, after the first patient studied in detail, not the holy day.) Historical and clinical features resemble those in classic hemophilia (HEMOPHILIA A), but patients present with fewer symptoms. Severity of bleeding is usually similar in members of a single family. Many patients are asymptomatic until the hemostatic system is stressed by surgery or trauma. Treatment is similar to that for hemophilia A. (From Cecil Textbook of Medicine, 19th ed, p1008)
| Excerpt | Relevance | Reference |
|---|---|---|
| " A sustained release dosage form is beneficial in terms of reducing the injection frequency and improving the therapeutic effectiveness." | 1.37 | Sustained release of transgenic human factor IX: preparation, characterization, and in vivo efficacy. ( Chang, LC; Chua, AC; Lai, SM; Lin, YJ; Yang, CY, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herbsleb, M | 1 |
| Hilberg, T | 1 |
| Chang, LC | 1 |
| Yang, CY | 1 |
| Chua, AC | 1 |
| Lin, YJ | 1 |
| Lai, SM | 1 |
2 other studies available for lactic acid and Hemophilia B
| Article | Year |
|---|---|
Maximal and submaximal endurance performance in adults with severe haemophilia.
Topics: Adolescent; Adult; Anthropometry; Exercise Test; Heart Rate; Hemophilia A; Hemophilia B; Humans; Lac | 2009 |
Sustained release of transgenic human factor IX: preparation, characterization, and in vivo efficacy.
Topics: Animals; Bleeding Time; Delayed-Action Preparations; Drug Compounding; Emulsions; Enzyme Stability; | 2011 |